National Center for Research Resources; Amended Notice of Meeting, 38406 [06-5995]
Download as PDF
<![CDATA[
38406
Federal Register / Vol. 71, No. 129 / Thursday, July 6, 2006 / Notices
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, 301–402–1030,
donzel@mail.nih.gov.
Dated: June 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5994 Filed 7–5–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Center for
Research Resources Special Emphasis
Panel, June 21, 2006, 2 p.m. to June 21,
2006, 4 p.m., National Institutes of
Health, One Democracy Plaza, 6701
Democracy Boulevard, Conference
Room 1087, Bethesda, MD 20892 which
was published in the Federal Register
on May 31, 2006, 71 FR 30943.
The date of the meeting has been
changed to July 18, 2006. The time and
location remains the same. The meeting
is closed to the public.
Dated: June 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5995 Filed 7–5–06; 8:45 am]
BILLING CODE 4140–01–M
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, Sequencing Technology RFA.
Date: July 18–19, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Hotel Rouge, 1315 16th Street,
Washington, DC 20036.
Contact Person: Ken D. Nakamura, PhD,
Scientific Review Administrator, Scientific
Review Branch, National Human Genome
Research Institute, National Institutes of
Health, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20582, 301–402–0838.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Human
Genome Research Institute, Special Emphasis
Panel, ELSI Public Consultation RFA.
Date: July 20, 2006.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW, Washington, DC 20037.
Contact Person: Rudy O. Pozzatti, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Human Genome
Research Institute, National Institutes of
Health, Bethesda, MD 20892, 301 402–0383.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: June 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5993 Filed 7–5–06; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Human Genome Research
Institutes; Notice of Closed Meetings
jlentini on PROD1PC65 with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Aug<31>2005
19:52 Jul 05, 2006
Jkt 208001
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Training in Computational Neuroscience:
From Biology to Model and Back Again.
Date: June 29, 2006.
Time: 8:30 a.m. to 5 a.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel, 1700 Tysons
Boulevard, McLean, VA 22102.
Contact Person: Murat Oz, PhD, Health
Scientist Administrator, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Neuroscience Center, Rm. 229,
MSC 8401, 6101 Executive Boulevard,
Bethesda, MD 20892, 301–435–1433,
moz2@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Member
Conflict.
Date: June 30, 2006.
Time: 2:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Gerald L. McLaughlin,
PhD, Scientific Review Administrator, Office
of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Blvd., Bethesda, MD
20892–8401, 301–402–6626,
gm145a@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Member
Conflict.
Date: July 18, 2006.
Time: 5 p.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Murat Oz, PhD, Health
Scientist Administrator, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Neuroscience Center, Rm. 229,
MSC 8401, 6101 Executive Boulevard,
Bethesda, MD 20892, 301–435–1433,
moz2@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
E:\FR\FM\06JYN1.SGM
06JYN1
]]>Agencies
[Federal Register Volume 71, Number 129 (Thursday, July 6, 2006)]
[Notices]
[Page 38406]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-5995]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Research Resources; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Center for Research Resources Special Emphasis Panel, June 21, 2006, 2
p.m. to June 21, 2006, 4 p.m., National Institutes of Health, One
Democracy Plaza, 6701 Democracy Boulevard, Conference Room 1087,
Bethesda, MD 20892 which was published in the Federal Register on May
31, 2006, 71 FR 30943.
The date of the meeting has been changed to July 18, 2006. The time
and location remains the same. The meeting is closed to the public.
Dated: June 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-5995 Filed 7-5-06; 8:45 am]
BILLING CODE 4140-01-M
